Anti-SPINK1 antibody (24-79)

Référence NB-22-36385-100ul

Conditionnement : 100μL

Marque : Neo Biotech

Contactez votre distributeur local :


Téléphone : +1 850 650 7790

  • Immunofluorescence analysis of HeLa cells using SPINK1 antibody . Blue: DAPI for nuclear staining.

General Info

Host: Rabbit
Applications: IF
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-SPINK1 (24-79) is suitable for use in Immunofluorescence research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: IF/ICC 1:50-1:200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.

Information

Gene Symbol: SPINK1
Gene ID: 6690
Uniprot ID: ISK1_HUMAN
Immunogen Region: 24-79
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 24-79 of human SPINK1 (NP_003113.2).
Immunogen Sequence: DSLGREAKCYNELNGCTKIY DPVCGTDGNTYPNECVLCFE NRKRQTSILIQKSGPC

Description

Function Serine protease inhibitor which exhibits anti-trypsin activity. In the pancreas, protects against trypsin-catalyzed premature activation of zymogens. In the male reproductive tract, binds to sperm heads where it modulates sperm capacitance by inhibiting calcium uptake and nitrogen oxide (NO) production.
Protein Name Serine Protease Inhibitor Kazal-Type 1
Pancreatic Secretory Trypsin Inhibitor
Tumor-Associated Trypsin Inhibitor
Tati
Cellular Localisation Secreted
Alternative Antibody Names Anti-Serine Protease Inhibitor Kazal-Type 1 antibody
Anti-Pancreatic Secretory Trypsin Inhibitor antibody
Anti-Tumor-Associated Trypsin Inhibitor antibody
Anti-Tati antibody
Anti-SPINK1 antibody
Anti-PSTI antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance